Pyxis Oncology Inc Capital Reinvestment Ratio

Latest as of June 2021: 0.13x

Pyxis Oncology Inc capital reinvestment ratio. Pyxis Oncology Inc (PYXS) has a Capital Reinvestment Ratio of 0.13x as of June 2021, meaning it reinvests 0% of its operating cash flow ($2.86 Million) in capital expenditures ($371.00K). Check cash flow reinvestment rate of Pyxis Oncology Inc to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.13x

Capex / Operating Cash Flow

Operating Cash Flow

$2.86 Million

USD

Capital Expenditures

$371.00K

USD

Data as of

Jun 2021

Most recent filing

Pyxis Oncology Inc Capital Reinvestment Ratio by Year (None–None)

Pyxis Oncology Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see how efficiently does Pyxis Oncology Inc generate cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow